SEC Comment Letter 0000000000-24-012870 to GRI Bio, Inc. (GRI)

GRI Bio, Inc.
Date: Nov. 20, 2024 · CIK: 0001824293 · Accession: 0000000000-24-012870

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-283234

Date

November 20, 2024

Author

Alan Campbell

Form

UPLOAD

Company

GRI Bio, Inc.

Letter

November 20, 2024 Marc Hertz President and CEO GRI Bio, Inc. 2223 Avenida De La Playa, #208 La Jolla, CA 92037 Re:GRI Bio, Inc. Registration Statement on Form S-3 Filed November 14, 2024 File No. 333-283234 Dear Marc Hertz: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Jason Miller, Esq.

Show Raw Text

November 20, 2024
Marc Hertz
President and CEO
GRI Bio, Inc.
2223 Avenida De La Playa, #208
La Jolla, CA 92037
Re:GRI Bio, Inc.
Registration Statement on Form S-3
Filed November 14, 2024
File No. 333-283234
Dear Marc Hertz:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Alan Campbell at 202-551-4224 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Jason Miller, Esq.

SecProbe.io